The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery
Eyelid Diseases, Periorbital Disorder, Hemorrhage
About this trial
This is an interventional supportive care trial for Eyelid Diseases
Eligibility Criteria
Inclusion Criteria: Adults age 18 and above undergoing periorbital oculoplastic surgery including but not limited to upper and lower blepharoplasty, four lid procedures, or dacryocystorhinostomy (DCR). Exclusion Criteria: - Adults unable to consent Individuals less than 18 years of age Prisoners Pregnant women. Known contradictions or sensitivities to study medication (tranexamic acid) Patients with known prior thromboembolic events Previous eyelid surgery or same-side DCR (RE-DCR) Has any type of coagulopathy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Tranexamic Acid Group
Placebo Group
Participants undergoing standard of care periorbital procedures will be randomized to receive tranexamic acid with lidocaine/epinephrine on one of their eyelids at the beginning of the scheduled operation before incision.
Participants undergoing standard of care periorbital procedures will be randomized to receive balanced salt solution with lidocaine/epinephrine on one of their eyelids at the beginning of the scheduled operation before incision.